This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To determine pretesting factors associated with elevated total homocysteine (tHcy) levels in a cohort of patients with acute ischemic stroke and to identify patient characteristics associated with physicians’ decisions to obtain tHcy levels in routine clinical practice.
Methods: Patient demographics, traditional stroke risk factors, and the results of tHcy tests were recorded for a consecutive series of adult patients with ischemic stroke admitted to an academic medical center from January 1997 to December 1999 (n = 674). Stroke subtype was classified using the TOAST (Trial of Org 10172 in Acute Stroke Treatment) criteria. Univariate analyses were used to identify patient characteristics associated with elevated tHcy levels and factors associated with tHcy testing. Multivariable stepwise logistic regression analyses were then used to identify the independent associations of univariately significant variables with tHcy testing.
Results: Of 674 patients, 131 (19.4%) were tested for tHcy. There were no associations between age, sex, stroke subtype, or the presence of other stroke risk factors and tHcy levels. Younger age (odds ratio [OR] = 0.54/decade, 95% CI = 0.46 to 0.62), the presence of hyperlipidemia (OR = 1.9, 95% CI = 1.2 to 2.9), diabetes (OR = 0.47, 95% CI = 0.29 to 0.78), and cardioembolic (OR = 0.47, 95% CI = 0.23 to 0.95) and small-vessel (OR = 0.43, 95% CI = 0.22 to 0.83) stroke subtypes were independently associated with tHcy testing.
Conclusions: Elevated tHcy levels were not associated with any of the studied characteristics of ischemic stroke patients. More research is needed to determine factors that aid in selecting patients for tHcy testing and improving diagnostic yield.
- Received April 30, 2002.
- Accepted July 28, 2002.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
